Cebis India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 8.32 Cr
as on 30-07-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.97 Cr
as on 30-07-2024
- Satisfied Charges ₹ 53.63 Cr
as on 30-07-2024
- Revenue 96.97%
(FY 2023)
- Profit -8630.67%
(FY 2023)
- Ebitda -3082.39%
(FY 2023)
- Net Worth -73.54%
(FY 2023)
- Total Assets 3.88%
(FY 2023)
About Cebis India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.32 Cr.
The company currently has active open charges totaling ₹19.97 Cr. The company has closed loans amounting to ₹53.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cebis India Limited India is Yati Chugh as CEO. Mulakala Kiran, Dopesh Mulakala, and Chintapatla Shravan serve as directors at the Company.
- CIN/LLPIN
U73100TG2018PLC127550
- Company No.
127550
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Secunderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cebis India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dopesh Mulakala  | Managing Director | 10-Oct-2018 | Current |
| Yati Chugh | CEO | 01-Jul-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chintapatla Shravan | Director | 18-Aug-2020 | Current |
| Mulakala Kiran | Director | 11-Mar-2020 | Current |
Financial Performance of Cebis India.
Cebis India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 96.97% increase. The company also saw a substantial fall in profitability, with a 8630.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cebis India?
In 2023, Cebis India had a promoter holding of 88.23% and a public holding of 11.77%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vanta Clinical Research LimitedActive 6 years 4 monthsMulakala Kiran, Dopesh Mulakala and 1 more are mutual person
Sarvotham Remedies LimitedActive 22 years 10 monthsMulakala Kiran, Dopesh Mulakala and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jun 2022 | ₹19.50 Cr | Open |
Others Creation Date: 28 Jun 2022 | ₹4.70 M | Open |
Others Creation Date: 01 Sep 2021 | ₹4.97 M | Satisfied |
How Many Employees Work at Cebis India?
Cebis India has a workforce of 37 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cebis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cebis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
